About the journal
- Diabetic Nephropathy and COVID-19: Fatal Connection?
- Mechanisms Connecting Diabetes Mellitus and Obesity
- Documented Cardiovascular Benefit of Empagliflozin in New American Diabetes Treatment Guidelines
- DPP4 Inhibitors in Chronic Kidney Disease and Their Potential to Protect Against Diabetic Nephropathy
- Impact of Oral Antidiabetics on Heart Failure